The global transdermal patches market is anticipated to grow at a significant CAGR of around 5.75% during the forecast period. The rising benefits of transdermal patches over oral and swallowing drugs (medications for gastrointestinal toxicity) that cause nausea and vomiting are driving the market's expansion. Transdermal patches are less inconvenient than intravenous or parenteral therapies since they are non-invasive. The key benefit of the patch includes regulated drug release to the patient, among others. Additionally, these patches are used in several applications for the treatment of migraine, hormones, pain, cardiovascular illness, neurological disease, and smoking cessation, among others. Further, due to reduced dose frequency, increased absorption reduces side effects, and drug input termination at any moment by removing the patch, due to which the transdermal mode of drug delivery is gaining popularity.
Impact of COVID-19 Pandemic on Global Transdermal Patches Market
The COVID-19 pandemic had disrupted the manufacturing operations of various industries across the globe owing to the nationwide lockdown in most of the countries to control the spread of the virus. Thus, it affected the overall demand for transdermal patches in the market. However, the COVID-19 pandemic had a beneficial effect on the market for transdermal patches. These patches make it possible to administer medications to a specific skin microenvironment in a safe, repeatable, and regulated manner. As a result, researchers working on a potential COVID-19 vaccination are looking into using a fingertip-sized skin patch to deliver the vaccine which in turn has a positive impact on the market.
Segmental Outlook
The global transdermal patches market is segmented based on type and application. Based on the type, the market is sub-segmented into the single-layer drug-in-adhesive, multi-layer drug-in-adhesive and matrix. Based on the application, the market is sub-segmented into pain relief, smoking reduction and cessation aid, overactive bladder and hormonal therapy.
Global Transdermal Patches Market Share by Application, 2021 (%)
The Smoking Reduction and Cessation Aid Holds a Prominent Share in the Global Transdermal Patches Market
The smoking reduction and cessation aid segment holds a prominent market share and is anticipated to grow significantly during the forecast period in the global transdermal patches market. According to the World Health Organization (WHO), COVID-19 is a disease that mostly affects the lungs. Smoking impairs lung function and makes it more difficult for the body to fight diseases such as viruses. As a result, during the pandemic, there was an increase in smoking cessation campaigning and awareness, supporting segmental growth. The segment's rapid rise can be attributed to a large number of smokers globally and growing awareness of the benefits of transdermal medication delivery for smoking cessation. According to the World Bank 2021, smoking is responsible for about 25% of all heart disease fatalities and 80% of lung cancer deaths, with many others being harmed by second-hand smoke.
Regional Outlooks
The global transdermal patches market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Among the regions, the Asia Pacific is anticipated to hold a significant share in the market followed by North America, and then Europe.
Global Transdermal Patches Market Growth, by Region 2022-2028
The Asia-Pacific Region is Expected to Hold Considerable Share in the Global Transdermal Patches Market
Asia-Pacific region holds a prominent share and is anticipated to grow fastest during the forecast period in the transdermal patches market. The presence of emerging countries such as China, Japan, India, and South Korea are taking big initiatives to fuel up the overall transdermal patches market. The growth can be attributed to an increase in the prevalence of chronic and acute diseases in the region, as well as a rise in demand for improved healthcare and pharmaceuticals, as well as rising understanding that allows for appropriate disease management. Furthermore, increased government funding for the management and treatment of a variety of ailments will boost the market growth in the region.
Market Players Outlook
The major companies serving the global transdermal patches market include Novartis AG, Fierce Pharma, 3M, Aveva, Teva Pharmaceutical Industries Ltd., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2020, Agile Therapeutics Inc. announced the launch of Twirla (Levonorgestrel and Ethinyl Estradiol) transdermal system, a new non-daily, non-invasive contraceptive patch, in the US. As a result, a large number of clinical trials of various types of pharmaceuticals would go underway, which may have a beneficial impact on the market's future growth.
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. 3M
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Aveva
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. Fierce Pharma
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. Novartis AG
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.1.5. Teva Pharmaceutical Industries Ltd.
3.1.5.1. Overview
3.1.5.2. Financial Analysis
3.1.5.3. SWOT Analysis
3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on Key Players
4. Market Segmentation
4.1. Global Transdermal patches Market by Type
4.1.1. Single-layer Drug-in-Adhesive
4.1.2. Multi-layer Drug-in-Adhesive
4.1.3. Matrix
4.2. Global Transdermal patches Market by Application
4.2.1. Pain Relief
4.2.2. Smoking Reduction and Cessation Aid
4.2.3. Overactive Bladder
4.2.4. Hormonal Therapy
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Acrux Limited
6.2. Agile Therapeutics Inc.
6.3. Cipla Inc.
6.4. Glenmark
6.5. ImQuest Biosciences
6.6. Luye Pharma Group
6.7. Mylan N.V.
6.8. Purdue Pharma L.P.
6.9. Rusan Pharma
6.10. Teikoku Pharma USA, Inc.
1. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL SINGLE-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL MULTI-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL MATRIX TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
6. GLOBAL PAIN RELIEF TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL SMOKING REDUCTION AND CESSATION AID TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL OVERACTIVE BLADDER TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL HORMONAL THERAPY TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
11. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
13. NORTH AMERICAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
14. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
16. EUROPEAN TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
19. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
20. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
21. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
22. REST OF THE WORLD TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL TRANSDERMAL PATCHES MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL TRANSDERMAL PATCHES MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL TRANSDERMAL PATCHES MARKET, 2022-2028 (%)
4. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL SINGLE-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL MULTI-LAYER DRUG-IN-ADHESIVE TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
8. GLOBAL PAIN RELIEF TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL SMOKING REDUCTION AND CESSATION AID TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL OVERACTIVE BLADDER TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL HORMONAL THERAPY TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. US TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
14. CANADA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
15. UK TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
16. FRANCE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
17. GERMANY TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
18. ITALY TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
19. SPAIN TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
20. REST OF EUROPE TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
21. INDIA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
22. CHINA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
23. JAPAN TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
24. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)
26. REST OF THE WORLD TRANSDERMAL PATCHES MARKET SIZE, 2021-2028 ($ MILLION)